The firm's listing covers sector Healthcare, and focus areas Biopharmaceuticals, Biotech, Neurodegenerative Diseases and Rare Disease; listed stages are Seed, Series A and Series B.

Dennis Podlesak (Investor) is listed as the contact to pitch at Canaan Partners’ Axcelius.

Frequently asked questions

What is Canaan Partners’ Axcelius?

Canaan Partners’ Axcelius is a venture capital firm whose one person on file is in New York, United States, with no portfolio on file. This page carries what the database does hold: investor type, sectors, focus areas, stages and the one person attached to it.

What does Canaan Partners’ Axcelius invest in?

Listed sectors include Healthcare; listed focus areas include Biopharmaceuticals, Biotech, Neurodegenerative Diseases and Rare Disease. There are no deals behind these tags: the database holds no portfolio for the firm, so they come from its own public description.

What stage does Canaan Partners’ Axcelius invest at?

Canaan Partners’ Axcelius is listed for Seed, Series A and Series B rounds in the database. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.

Who should I pitch at Canaan Partners’ Axcelius?

One person at Canaan Partners’ Axcelius is on file, listed as a contact for the firm, with their own profile page.

How do I contact Canaan Partners’ Axcelius?

Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal